Hopkins, Ria E.
Degenhardt, Louisa
Campbell, Gabrielle
Farnbach, Sara
Gisev, Natasa
Funding for this research was provided by:
National Health and Medical Research Council (1190977, 1073858)
National Drug and Alcohol Research Centre (n/a)
Article History
Received: 12 September 2022
Accepted: 8 December 2022
First Online: 31 December 2022
Declarations
:
: Ethical approval for this study was obtained from the University of New South Wales Human Research Ethics Committee (approval no. HC200517). All participants received a copy of the Participant Information Statement and Consent Form and provided informed consent prior to the interview. This study was conducted in accordance with relevant guidelines and regulations including the Declaration of Helsinki, Australian National Health and Medical Research Council guidance, and institutional requirements.
: Not applicable.
: LD and GC report investigator-driven untied educational grants from Reckitt Benckiser/Indivior; LD has received investigator-initiated untied educational grants from Mundipharma Limited; LD has received research grants from Seqirus; all of these have been outside the submitted work. All other authors declare no competing interests.